These results suggest that on the one hand, amygdalin may indirectly inhibit the C3a cleavage process by suppressing the expression of the upstream molecule C1s in the complement system, and on the other hand, amygdalin may directly inhibit C3 to exert anti-RA effects. Here, C1S is linked to rheumatoid arthritis.